A number of lists exist for the leading device companies in orthopedics, and we’re nearly always perplexed by them. We don’t believe them to be accurate. Here’s why.
Every public device company reports revenue differently. In other words, they don’t all segment their sales in the same way. And some may not segment orthopedics from other medical device revenue. Private companies are a whole different story, since they don’t publicly report.
We “bucket” revenue into six primary segments in order to generate apples-to-apples comparisons. This is a tedious and ever-changing process, as acquisitions and divestitures are a common occurrence. We do this for public and private companies by leveraging our proprietary knowledge of those companies and our relationships with analysts and insiders.
We continually critique and seek validation of our numbers, which is why we believe that they are the most accurate representation available for you.
In considering the top 10 players, Stryker’s acquisition of K2M helped them jump Zimmer Biomet for the #2 position in 2019. Stryker again is on our radar due to their pending acquisition of Wright Medical, #8 on our list. Click on the image to view which company will take the #10 position if the Stryker/Wright Medical deal is finalized in 2H2020.
A number of lists exist for the leading device companies in orthopedics, and we’re nearly always perplexed by them. We don’t believe them to be accurate. Here’s why.
Every public device company reports revenue differently. In other words, they don’t all segment their sales in the same way. And some may not segment orthopedics from other...
A number of lists exist for the leading device companies in orthopedics, and we’re nearly always perplexed by them. We don’t believe them to be accurate. Here’s why.
Every public device company reports revenue differently. In other words, they don’t all segment their sales in the same way. And some may not segment orthopedics from other medical device revenue. Private companies are a whole different story, since they don’t publicly report.
We “bucket” revenue into six primary segments in order to generate apples-to-apples comparisons. This is a tedious and ever-changing process, as acquisitions and divestitures are a common occurrence. We do this for public and private companies by leveraging our proprietary knowledge of those companies and our relationships with analysts and insiders.
We continually critique and seek validation of our numbers, which is why we believe that they are the most accurate representation available for you.
In considering the top 10 players, Stryker’s acquisition of K2M helped them jump Zimmer Biomet for the #2 position in 2019. Stryker again is on our radar due to their pending acquisition of Wright Medical, #8 on our list. Click on the image to view which company will take the #10 position if the Stryker/Wright Medical deal is finalized in 2H2020.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.